HCM
EXAS

Highline Capital Management’s Exact Sciences EXAS Stock Holding History

Highline Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-50,609
Closed -$4.4M – 23
2020
Q2 		$4.4M Buy
+50,609
New +$4.04M 3.58% 14

Other funds holding EXAS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Highline Capital Management's EXAS Position: Q3 2020 in Review

Highline Capital Management sold out of Exact Sciences (EXAS) in Q3 2020, closing a stake of 50,609 shares — an estimated $4.4M sold.

Highline Capital Management first reported a position in EXAS in Q2 2020 and held it in 1 quarter. The position peaked at $4.4M in Q2 2020. 516 funds tracked by Wall St. Rank hold EXAS as of Q3 2020.

  • Highline Capital Management reported no remaining Exact Sciences position as of Q3 2020 after selling out during the quarter.
  • Highline Capital Management sold 50,609 Exact Sciences shares in Q3 2020, an estimated $4.4M.
  • Highline Capital Management first reported a position in Exact Sciences in Q2 2020 and held it in 1 quarter.
  • Highline Capital Management's Exact Sciences position peaked at $4.4M in Q2 2020.
  • 516 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2020.

Based on Highline Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.